From VIDO director of facilities to a world of possibilities
During the work week, Cam Ewart serves as the director of facilities at one of the most advanced high-security infectious disease research facilities in the world.
USask recognizes Roy, Banerjee, Adewole as top researchers for 2026
The University of Saskatchewan (USask) is honouring Dr. Wendy Roy (PhD) with its top academic award of Distinguished Researcher for 2026.
VIDO researchers advancing technology to better understand immune responses
Dr. Neeraj Dhar (PhD), principal scientist at the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO), is looking to better understand immune responses to specific diseases like tuberculosis — a disease that targets the respiratory system — and the therapies being developed to combat them.
VIDO to undergo federal recertifying and key upgrades as Canada’s Centre for Pandemic Research
Inside VIDO’s work to stay ahead of the next pandemic
From cutting‑edge preclinical models to ambitious next‑generation vaccines, researchers at VIDO are working with CEPI to help the world move faster - and smarter - when the next pandemic threat emerges.
Top 5 things to know about Hantavirus and how VIDO is helping reduce risk
As Canadians begin spring cleaning, an often-overlooked health risk can surface alongside the dust. Illness caused by hantavirus is rare but serious, and researchers at VIDO are working to better understand these viruses and reduce the risk of human infection.
Researchers uncover unexpected limit to SARS-CoV-2’s immune defenses
A new study has revealed that while SARS-CoV-2 can weaken part of the body’s early immune response, it may also unintentionally trigger another defense that helps cells fight back.
Building Canada’s vaccine expertise: From the classroom to the front lines
Canada’s ability to respond to emerging infectious diseases depends not only on cutting-edge research, but on the development of a strong, well-trained scientific workforce.
VIDO: Advancing tuberculosis research for a healthier world
From developing new vaccines to uncovering drug targets, researchers at VIDO are working to combat tuberculosis, a persistent global health threat that remains one of the leading infectious killers worldwide.
Six years later: How VIDO helped respond to the COVID-19 pandemic
VIDO reflects on its response to the COVID-19 pandemic and how that work continues to shape Canada’s preparedness for future health threats.
From proof of concept to real-world impact: partnering with VIDO in One Health innovation
Whether partners are at an early-stage biotech building their first vaccine candidate or an established company expanding their infectious disease pipeline, progress depends on one thing: the right partner that can transform promising science to proven results.
CIHR funding supports VIDO research to strengthen outbreak and pandemic preparedness
Pandemic preparedness has never been more important, and researchers at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan (USask) are exploring new research and response strategies with the support of government funding.
Protecting Canadians and building sovereignty with domestic vaccine manufacturing
The Vaccine Development Centre at USask’s VIDO provides the expertise and infrastructure to ensure Canada is ready to respond quickly to emerging health threats and support national security.
USask’s VIDO secures provincial funding to advance priority animal health research and knowledge translation
Funding from the provincial and federal government is enabling VIDO to advance animal health research and engagement with livestock producers across Saskatchewan.